Media Pack
News

Current Edition

Volume 16 Issue 2
 
news

FDA Solicits mHealth, Wearable Tech Info For Clinical Trials

The U.S. Food and Drug Administration (FDA) is seeking input from relevant stakeholders on how new technologies — including mobile health technology (mHealth), teleme...
3 November 2015 news | North America | Regional News
Continue Reading →
news

CluePoints and Widler & Schiemann Collaborate on Complete Risk-Management Solution for Clinical Trials in Line with New Industry Guidance

Partnership will combine CluePoints' Risk-Based Monitoring Software with Widler & Schiemann's Consultancy Services 2 November 2015 Cambridge, MA - CluePoints, a l...
2 November 2015 news | North America | Regional News
Continue Reading →
news

Macrocure (MCUR) Phase III Clinical Trial of CureXcell Missed Primary Endpoint

Macrocure Ltd. (NASDAQ: MCUR) today announced that results from a pivotal Phase 3 multicenter, randomized, double-blind, parallel-group, sham-controlled study (MC-102...
28 October 2015 news | North America | Regional News
Continue Reading →
news

16 First Time Endovascular Clinical Trial Results to be presented at VIVA 15

LAS VEGAS, Oct. 27, 2015 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervent...
28 October 2015 news | North America | Regional News
Continue Reading →
news

Science 37 Secures $6.5M Series A Funding To Accelerate Clinical Trial Research

LOS ANGELES, Oct. 20, 2015 /PRNewswire/ -- Science 37 (http://science37.com), a technology-enabled clinical research company, today announced the completion of a $6.5...
20 October 2015 news | North America | Regional News
Continue Reading →
Europe

Savolitinib Completes Enrolment for Phase II Clinical Trial in Papillary Renal Cell Carcinoma

Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, and AstraZeneca AB (pu...
13 October 2015 Europe | news | North America | Regional News
Continue Reading →
news

Roche Drug First to Clear Clinical Trials for Hard-to-Treat Form of Multiple Sclerosis

Switzerland's Roche has moved into pole position in the race to launch the world's first treatment for progressive multiple sclerosis but smaller players are working ...
1 October 2015 news | North America | Regional News
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte